Promeditec and ANSYS

Luca Emili, CEO In Silico Trials, discusses the importance of using modern technologies like simulation to accelerate the FDA medical device and pharmaceutical approval process.

For more information read "A Healthy Future".
I want to receive updates and other offers from ANSYS and its partners. I can unsubscribe at any time. ANSYS Privacy Notice